Physician profile
James E Johnson
NPI 1831126713
$2,821.38
in general payments reported to CMS, 2019-2025
19 companies · $48.77 in 2025
The $48.77 reported for 2025 was less than what a typical Pain Medicine (Anesthesiology) provider received nationally (typical 2025 total: $458).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $868 · 2020: $267 · 2021: $396 · 2022: $615 · 2023: $217 · 2024: $409 · 2025: $48.77.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $674.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $674.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nevro Corp. | $873.93 | 2019-2024 | Senza |
| Spinal Simplicity, LLC | $546.72 | 2022-2024 | Ha Minuteman G3-R |
| Abbott Laboratories | $484.91 | 2019-2025 | Proclaim, Eterna |
| Medtronic USA, INC. | $158.45 | 2019-2020 | |
| Pfizer INC. | $149.79 | 2019-2021 | |
| Janssen Biotech, INC. | $113.03 | 2022-2023 | Simponi Aria, Stelara, Simponi |
| Medtronic, INC. | $85.54 | 2021 | |
| Aesculap, INC. | $83.20 | 2022 | |
| Merck Sharp & Dohme LLC | $71.34 | 2021-2024 | Keytruda, Welireg |
| Spr Therapeutics, INC | $39.34 | 2020 | |
| Novartis Pharmaceuticals Corporation | $37.48 | 2019-2022 | |
| Nalu Medical, INC. | $31.64 | 2024 | Nalu Neurostimulation System |
| Tersera Therapeutics LLC | $29.92 | 2023 | Zoladex |
| Revance Therapeutics, INC. | $25.11 | 2024 | Daxxify |
| Ani Pharmaceuticals, INC. | $22.03 | 2023 | Purified Cortrophin Gel |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $20.62 | 2020 | |
| Astrazeneca Pharmaceuticals Lp | $20.15 | 2022 | |
| Ipsen Biopharmaceuticals, INC | $14.56 | 2022 | |
| Arbor Pharmaceuticals, INC. | $13.62 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Johnson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.